Cibc World Market Inc. acquired a new stake in Ventas, Inc. (NYSE:VTR – Free Report) during the second quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 54,912 shares of the real estate investment trust’s stock, valued at approximately $4,876,000.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. NewEdge Advisors LLC raised its position in shares of Ventas by 856.1% in the first quarter. NewEdge Advisors LLC now owns 7,926 shares of the real estate investment trust’s stock valued at $545,000 after purchasing an additional 7,097 shares during the period. Empowered Funds LLC grew its stake in Ventas by 6.8% in the 1st quarter. Empowered Funds LLC now owns 8,373 shares of the real estate investment trust’s stock valued at $576,000 after buying an additional 536 shares during the last quarter. Woodline Partners LP grew its stake in Ventas by 46.8% in the 1st quarter. Woodline Partners LP now owns 36,826 shares of the real estate investment trust’s stock valued at $2,532,000 after buying an additional 11,739 shares during the last quarter. Focus Partners Wealth raised its holdings in Ventas by 130.4% in the 1st quarter. Focus Partners Wealth now owns 21,613 shares of the real estate investment trust’s stock worth $1,486,000 after acquiring an additional 12,233 shares during the period. Finally, Gamco Investors INC. ET AL acquired a new position in Ventas during the 2nd quarter worth $805,000. 94.18% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
VTR has been the subject of a number of recent analyst reports. KeyCorp upped their price target on shares of Ventas from $90.00 to $95.00 and gave the company an “overweight” rating in a report on Thursday, May 7th. Citigroup increased their target price on Ventas from $100.00 to $110.00 and gave the company a “buy” rating in a research note on Tuesday, August 4th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a $100.00 price target on shares of Ventas in a research report on Tuesday, June 16th. Scotiabank cut their price target on Ventas from $95.00 to $88.00 and set a “sector perform” rating for the company in a report on Thursday, June 18th. Finally, BMO Capital Markets increased their price objective on Ventas from $105.00 to $107.00 and gave the company an “outperform” rating in a research report on Tuesday, August 11th. Fourteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $98.00.
Ventas Stock Performance
Shares of NYSE VTR opened at $93.84 on Wednesday. The firm has a market capitalization of $48.14 billion, a price-to-earnings ratio of 173.79, a PEG ratio of 2.16 and a beta of 0.69. Ventas, Inc. has a one year low of $66.38 and a one year high of $101.60. The business has a fifty day simple moving average of $91.76 and a 200 day simple moving average of $87.38. The company has a current ratio of 0.44, a quick ratio of 0.44 and a debt-to-equity ratio of 0.86.
Ventas (NYSE:VTR – Get Free Report) last posted its quarterly earnings results on Wednesday, July 29th. The real estate investment trust reported $0.97 earnings per share for the quarter, topping analysts’ consensus estimates of $0.96 by $0.01. The firm had revenue of $1.73 billion for the quarter, compared to the consensus estimate of $1.68 billion. Ventas had a net margin of 4.08% and a return on equity of 1.99%. The business’s revenue was up 21.7% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.87 earnings per share. Sell-side analysts expect that Ventas, Inc. will post 3.89 EPS for the current year.
Insider Activity at Ventas
In other Ventas news, Director Michael J. Embler bought 2,500 shares of the firm’s stock in a transaction dated Wednesday, June 3rd. The shares were acquired at an average cost of $78.81 per share, for a total transaction of $197,025.00. Following the transaction, the director owned 19,202 shares in the company, valued at approximately $1,513,309.62. The trade was a 14.97% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. Insiders own 0.53% of the company’s stock.
About Ventas
Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.
Ventas’ business model combines property ownership with active asset management and capital markets activity.
Featured Articles
- Five stocks we like better than Ventas
- Pathward’s Credit Scare Tests Its Comeback Story
- Wiring the AI Boom: Rumble’s $13.7B Pivot
- StoneX: Too Far Too Fast?
- DICK’s Sporting Goods Faces Pain Now for a Bigger Prize
Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTR – Free Report).
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.
